US › Healthcare

Adlai Nortye Ltd. American Depositary Shares (ANL)

US · Healthcare · Biotechnology

$13.00+0.08%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$2.5M
Revenue YoY
0.0%
Net profit
$-8.6M
Profit YoY
+35.0%
EPS
$0.00
EPS estimate
$0.00
Net margin
-343.9%

Key statistics

Market cap
$836.5M
Forward P/E
0.0
P/B
82.76
Book value
$-0.21
EPS (TTM)
$-1.11
52-week high
$17.25
52-week low
$0.88
50-day MA
$11.13
200-day MA
$7.48
Beta
1.12

Analyst view

Analysts rate Adlai Nortye Ltd. American Depositary Shares a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $28.60.

Shareholding

Insiders
0.01%
Institutions
15.99%

Largest institutional holders

FundStake
VR Adviser, LLC5.47%
Cormorant Asset Management, LLC4.93%
Squadron Capital Management LLC2.15%
Balyasny Asset Management LLC1.49%
Millennium Management LLC1.16%
Casdin Capital, LLC0.92%
Adage Capital Partners Gp LLC0.92%
SUPERSTRING CAPITAL MANAGEMENT LP0.71%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Adlai Nortye Ltd. American Depositary Shares — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.